Nd:YAG laser laparoscopy for ovarian endometriomas

Area of Science:

• Minimally Invasive Gynecological Surgery
• Reproductive Endocrinology
• Laser Therapeutics

Background:

• Ovarian endometriomas are a common gynecological condition associated with infertility and dysmenorrhea.
• Laparoscopic surgery is a standard treatment, but alternative methods for endometrial cyst management are continually explored.
• The role of laser technology in gynecological procedures requires further investigation for efficacy and safety.

Purpose of the Study:

• To evaluate the efficacy and safety of Neodymium-doped yttrium aluminum garnet (Nd:YAG) laser contact irradiation for treating ovarian endometriomas.
• To assess the impact of this treatment on infertility and dysmenorrhea.
• To determine the effect on serum cancer antigen 125 (CA-125) levels.

Main Methods:

• Thirty patients diagnosed with ovarian endometriomas underwent laparoscopic treatment using Nd:YAG laser contact irradiation with a cone-shaped sapphire probe.
• Procedures included cyst aspiration, endometrioma removal, adhesiolysis, uterine nerve ablation, and peritoneal endometriosis coagulation.
• Patient outcomes were assessed based on pregnancy rates, pain relief (dysmenorrhea), and changes in serum CA-125 levels.

Main Results:

• No intraoperative or postoperative complications were reported in the thirty patients.
• Six out of sixteen patients (37.5%) seeking treatment for infertility achieved pregnancy post-procedure.
• Thirteen out of fourteen patients (92.8%) experiencing dysmenorrhea reported significant pain relief. Serum CA-125 levels decreased significantly postoperatively.

Conclusions:

• Nd:YAG laser contact irradiation, utilizing a cone-shaped sapphire probe, provides effective incision and lysis of ovarian endometriomas at low power settings.
• This minimally invasive laparoscopic technique demonstrates significant efficacy in improving fertility outcomes and alleviating pain associated with ovarian endometriomas.
• The procedure is safe and well-tolerated, with a notable reduction in serum CA-125 levels, suggesting a potential role in managing endometriosis.